Abstract
HER2 staining and clinical outcomes in patients with stage I serous endometrial cancers (1288)
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have